North Dallas Bank & Trust’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.3M Sell
9,159
-10
-0.1% -$2.15K 1.37% 20
2026
Q1
$1.99M Sell
9,169
-85
-0.9% -$18.9K 1.35% 21
2025
Q4
$2.11M Buy
+9,254
New +$2.11M 1.38% 18
2025
Q2
$1.68M Buy
+9,067
New +$1.69M 1.28% 23

Other funds holding ABBV

North Dallas Bank & Trust's ABBV Position: Q2 2026 in Review

North Dallas Bank & Trust reduced its AbbVie (ABBV) stake by 0.11% in Q2 2026, selling an estimated $2.15K and leaving 9,159 shares worth $2.3M. The position accounts for 1.37% of the portfolio, ranked #20.

North Dallas Bank & Trust first reported a position in ABBV in Q2 2025 and has held it in 4 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • North Dallas Bank & Trust held 9,159 shares of AbbVie worth $2.3M as of Q2 2026.
  • North Dallas Bank & Trust sold 10 AbbVie shares in Q2 2026, an estimated $2.15K.
  • AbbVie made up 1.37% of North Dallas Bank & Trust's portfolio in Q2 2026, its #20 holding.
  • North Dallas Bank & Trust first reported a position in AbbVie in Q2 2025 and has held it in 4 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on North Dallas Bank & Trust's 13F filing for Q2 2026, filed 13 Jul 2026.